PSIL – AdvisorShares Psychedelics ETF
AdvisorShares Psychedelics ETF (PSIL) is a Miscellaneous Sector ETF, issued by AdvisorShares, $20.7M in assets, 0.99% expense ratio.
Returns as of Oct 23, 2026: 1 week +3.7%, 1 year +53.7%.
Actively invests in companies deriving revenue from psychedelic drugs. Focuses on publicly listed life sciences firms in the psychedelics business.
Top holdings
- CMPS – Compass Pathways Plc, 9.0%
- SUPN – Supernus Pharmaceuticals Inc, 7.6%
- RLMD – Relmada Therapeutics Inc, 6.7%
- ALKS – Alkermes Plc, 5.7%
- GHRS – GH Research PLC, 5.6%
- NBIX – Neurocrine Biosciences Inc, 5.2%
- ANRO – Alto Neuroscience, Inc., 4.8%
- NRXP – NRX Pharmaceuticals Inc, 4.7%
- HELP – Cybin Inc., 4.0%
- JNJ – Johnson & Johnson, 3.6%
- ABBV – AbbVie Inc, 3.4%
- STIM – Neuronetics Inc, 3.2%
- NEUP – Neuphoria Therapeutics Inc, 2.9%
- SILO – Silo Pharma Inc, 1.2%
- NUMI – Numinus Wellness Inc, 1.0%
- QNTM – Quantum BioPharma Ltd.